-
1.N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them 有权
标题翻译: N-(2-芳基 - 丙酰基) - 磺酰胺和含有它们的药物制剂公开(公告)号:US06881755B2
公开(公告)日:2005-04-19
申请号:US10460203
申请日:2003-06-13
申请人: Riccardo Bertini , Cinzia Bizzarri , Vilma Sabbatini , Gianfranco Caselli , Marcello Allegretti , Maria Candida Cesta , Carmelo Gandolfi , Marco Mantovanini , Francesco Colotta , Stefano Porzio
发明人: Riccardo Bertini , Cinzia Bizzarri , Vilma Sabbatini , Gianfranco Caselli , Marcello Allegretti , Maria Candida Cesta , Carmelo Gandolfi , Marco Mantovanini , Francesco Colotta , Stefano Porzio
IPC分类号: A61P9/08 , A01N37/18 , A61K20060101 , A61K31/16 , A61K31/165 , A61K31/18 , A61K31/195 , A61K31/275 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/4035 , A61K31/445 , A61K31/497 , A61K31/537 , A61P11/00 , A61P13/12 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/02 , A61P37/06 , C07C20060101 , C07C221/00 , C07C233/11 , C07C311/03 , C07C311/04 , C07C311/05 , C07C311/45 , C07C311/47 , C07C311/50 , C07C311/51 , C07D213/82 , C07D295/08 , C07D333/20
CPC分类号: C07C311/51 , C07D209/46 , C07D213/34 , C07D213/71 , C07D213/81 , C07D213/82 , C07D295/088 , C07D333/22 , C07D333/24
摘要: The compounds of formula 1, wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.
摘要翻译: 式1化合物,其中R和R 2如本公开所定义,可用于预防和治疗由于炎性部位多形核嗜中性粒细胞(PMN白细胞)的加剧募集而导致的组织损伤 。
-
2.N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them 有权
标题翻译: N-(2-芳基 - 丙酰基) - 磺酰胺和含有它们的药物制剂公开(公告)号:US06887903B1
公开(公告)日:2005-05-03
申请号:US09830075
申请日:1999-10-14
申请人: Riccardo Bertini , Cinzia Bizzarri , Vilma Sabbatini , Gianfranco Caselli , Marcello Allegretti , Maria Candida Cesta , Carmelo Gandolfi , Marco Mantovanini , Francesco Colotta , Stefano Porzio
发明人: Riccardo Bertini , Cinzia Bizzarri , Vilma Sabbatini , Gianfranco Caselli , Marcello Allegretti , Maria Candida Cesta , Carmelo Gandolfi , Marco Mantovanini , Francesco Colotta , Stefano Porzio
IPC分类号: A61P9/08 , A01N37/18 , A61K20060101 , A61K31/16 , A61K31/165 , A61K31/18 , A61K31/195 , A61K31/275 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/4035 , A61K31/445 , A61K31/497 , A61K31/537 , A61P11/00 , A61P13/12 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/02 , A61P37/06 , C07C20060101 , C07C221/00 , C07C233/11 , C07C311/03 , C07C311/04 , C07C311/05 , C07C311/45 , C07C311/47 , C07C311/50 , C07C311/51 , C07D213/82 , C07D295/08 , C07D333/20
CPC分类号: C07C311/51 , C07D209/46 , C07D213/34 , C07D213/71 , C07D213/81 , C07D213/82 , C07D295/088 , C07D333/22 , C07D333/24
摘要: The compounds of formula 1 wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.
摘要翻译: 其中R 1和R 2 2如本公开所定义的式1化合物可用于预防和治疗由于炎性部位多形核嗜中性粒细胞(PMN白细胞)的加剧性募集而导致的组织损伤。
-